Insights

Stay up to date on PsychoGenics’ latest research, press releases, and industry developments in preclinical drug discovery. Combine our expertise with yours to spark the translational power of your next CNS breakthrough.

Sleep/Wake and Pharmaco-EEG Capabilities

October 22, 2025
Read More
POSTER

Standardized Spinal Cord Injury Platform for Preclinical Research

June 24, 2025
Read More

Sleep/Wake and Pharmaco-EEG Capabilities

October 22, 2025
Read More
POSTER

Standardized Spinal Cord Injury Platform for Preclinical Research

June 24, 2025
Read More
RESEARCH UPDATES

Autism Spectrum Disorder (ASD) is a multifaceted neurodevelopmental condition characterized by challenges in social interaction, communication, and behavior. 

June 24, 2025
Read More
POSTER

Evaluation of Locomotor and Sensory Recovery in a Cervical Hemi-Contusion Model Using Standardized Methods.

June 20, 2025
Read More
POSTER

Therapeutic Potential of Investigational Drugs for Rett Syndrome Assessed with Behavioral Profiles in Animal Models

June 9, 2025
Read More
RESEARCH UPDATES

In vivo electrophysiology in anesthetized rodents

June 5, 2025
Read More
RESEARCH UPDATES

Preclinical Models of Huntington’s Disease

May 23, 2025
Read More
PUBLICATION

Target Validation Studies of PS48, a PDK-1 Allosteric Agonist, for the Treatment of Alzheimer’s Disease Phenotype in APP/PS1 Transgenic Mice

April 29, 2025
Read More
PUBLICATION

Developmental deletion of amyloid precursor protein precludes transcriptional and proteomic responses to brain injury

April 29, 2025
Read More